🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

2 Top Pot Stocks to Buy in November

Published 2020-10-29, 07:49 a/m
2 Top Pot Stocks to Buy in November

Weed stocks aren’t the most popular stocks on the Toronto Stock Exchange anymore, but that doesn’t mean you should ignore them. In fact, they are selling for very low prices today versus where they were last year. Canadian investors should at least have their eye on top cannabis stocks to buy in November.

Here are two pot stocks that you might consider buying in November.

Canopy Growth: A high-growth pot stock Canopy Growth (TSX:WEED)(NYSE:CGC) fell to $12.96 during the March market sell-off from a 52-week high of $33.86. As of Wednesday, investors are trading the stock for around $24.82 per share.

David Klein, CEO of Canopy Growth, made this statement in the stock’s last earnings report to shareholders:

“We grew our revenue year-over-year and are seeing market share improvement, notably achieving number one market share in cannabis-infused beverages in the Canadian market. We are implementing a renewed corporate strategy with the appointment of a new leadership team which will focus on delivering quality products to our consumers, positioning our business for continued growth. The proposed retooled Acreage announcement refocuses our entry for the evolving U.S. market, where we are seeing increased momentum.”

Canopy Growth still has a negative levered free cash flow of -$601.85 million. Moreover, the stock’s price-to-sales ratio of 21.67 is high, even for a growth stock. Investors should look at growing free cash flow with a mindfulness over the price-to-sales ratio before buying this pot stock.

Luckily, Canopy Growth is one of the top growth stocks in Canada today. Thus, if you do want to invest in a marijuana stock, Canopy Growth is a strong option.

Aurora Cannabis: A cheaper cannabis option Aurora Cannabis (TSX:ACB)(NYSE:ACB) was down-trending before the March 2020 sell-off. In the past year, the stock has fallen to a 52-week low of $4.93 from a 52-week high of $61.80. At the time of writing, investors are trading the stock for $5.18 per share.

Aurora Cannabis will report earnings on November 9.

The last time Aurora reported earnings, Miguel Martin, CEO of Aurora, sounded confident in the company’s ability to expand revenue:

“My focus is therefore to re-position the Canadian consumer business immediately. We look to expand beyond the value flower segment, leverage our capabilities in science and product innovation and put our effort on a finite number of emerging growth formats. This entails prioritizing our San Rafael, Aurora and Whistler premium brands in flower, pre-rolls and vapor, which will be shortly followed by strategic marketing and innovation efforts in concentrates and edibles.”

Aurora Cannabis also has a negative free cash flow of -$504.87 million. The stock’s price-to-sales ratio, however, is much lower than Canopy Growth at 2.21. The reason being is that investors are concerned about debt, low cash, and low revenue-growth numbers.

Cannabis investors shouldn’t completely ignore Aurora, especially at around $5 per share. Further, the company is re-strategizing under new CEO Miguel Martin, who just might turn things around for the company.

Foolish takeaway If you want to buy marijuana stocks, Canopy Growth and Aurora are both great options. At the moment, investors seem to be more confident in Canopy Growth to deliver growing quarterly revenue, which now stands at 22% on a year-over-year basis.

However, Canopy Growth also has a very high market capitalization of around $9 billion when its revenue is only $418.71 million. By comparison, Aurora Cannabis has a market capitalization of $617.37 million, only 2.21 times its current trailing 12-month revenue.

Aurora is the cheaper option, while shareholders have already priced in revenue growth to its share price.

The post 2 Top Pot Stocks to Buy in November appeared first on The Motley Fool Canada.

Fool contributor Debra Ray has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2020

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.